Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials
Cancers · 17.03.2026 · 18 (6) · 964
DOI: 10.3390/cancers18060964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.03.2026. Verfasst von Elettra Merola und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pulmonary neuroendocrine neoplasms comprise a heterogeneous group of epithelial lung tumors characterized by varying degrees of differentiation and biological aggressiveness. Among high-grade types, large cell neuroendocrine carcinoma (LCNEC) is an uncommon but clinically significant entity, representing approximately 3% of lung cancers, with the optimal first-line therapeutic approach remaining uncertain. Our aim was to evaluate the available prospective therapeutic evidence in patients with advanced or metastatic pulmonary LCNEC, defining the current evidence and identifying key gaps to inform future research.
Methods
A systematic literature search was conducted using PubMed, Scopus, and Web of Science (last update: 9 August 2025). Endpoints included the evaluation of clinical outcomes from interventional trials and safety.
Results
Overall, 2139 records were identified through the database search and handsearching. After removal of duplicates and non-eligible records, only 4 prospective, non-randomized studies were eligible for the systematic review. Due to the risk of bias and substantial methodological variability, a meta-analysis could not be reliably performed. Three trials investigated first-line platinum-based chemotherapy regimens, while only one study evaluated immunotherapy in lung LCNEC. Overall clinical outcomes were modest, with benefits appearing limited in duration, with median PFS consistently
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
- Department of Medicine, Baylor College of Medicine, One Baylor Plaza Blvd, Houston, TX 77030, USA.
- Unit of Endocrinology, AOU Sassari, Viale San Pietro 43b, 07100 Sassari, Italy.
ORCID-Profile: Elettra Merola, Maria Pina Dore, Giuseppe Fanciulli
Zitieren
APA
Merola, E., Dore, M. P., & Fanciulli, G. (2026). Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials. Cancers, 18(6), 964. https://doi.org/10.3390/cancers18060964
Vancouver
Merola E, Dore MP, Fanciulli G. Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials. Cancers. 2026;18(6):964. doi:10.3390/cancers18060964
BibTeX
@article{Merola2026,
author = {Merola, Elettra and Dore, Maria Pina and Fanciulli, Giuseppe},
title = {Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials},
journal = {Cancers},
year = {2026},
volume = {18},
number = {6},
pages = {964},
doi = {10.3390/cancers18060964}
}
EUVIMED